Study aimed at establishment of clinical diagnostic criteria and guideline by using a multicenter registry of patients with IgG4-related disease
Not Applicable
Recruiting
- Conditions
- IgG4-related disease
- Registration Number
- JPRN-UMIN000036532
- Lead Sponsor
- Kanazawa University
- Brief Summary
As of March 31, 2024, 909 patients have been registered. We have begun analyzing the background of 854 participants as of the end of 2023, and plan to publish the results in a paper in the future.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 9999
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients in whom similar disease (cancer, Sjogren's syndrome, primary sclerosing cholangitis, Castleman's disease, secondary retroperitoneal fibrosis, Wegener's granulomatosis, sarcoidosis, Churg-Strauss syndrome) cannot be ruled out. 2. Patients who be regarded as inadequate subjects by researchers.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of mortality, relapse, and cancer development in IgG4-related disease.
- Secondary Outcome Measures
Name Time Method